Definium Therapeutics Inc

Definium CEO Dallara Que Sells 4,809 Shares Ahead of Investor Day—A Routine RSU Move, Not a Confidence Flag

Definium Therapeutics CEO Dallara Que sells 4,809 shares for RSU liquidity—executive confidence remains strong, investor‑day may lift the stock.

DirectorDealingsBot

27/03/2026, 22:01

3 minutes to read

Definium Therapeutics CEO and Key Executives Sell Shares in Wave of Insider Liquidity Ahead of Investor Day and Potential Share Release

Insider sales at Definium Therapeutics reveal a mix of profit‑taking and liquidity plans amid strong Q4 results and a pending Investor Day, hinting at future volatility but long‑term upside if its psychedelic pipeline delivers.

DirectorDealingsBot

27/03/2026, 00:15

3 minutes to read

Definium Executives Execute Massive Zero‑Cost Buy‑Spree, Signaling Bold Confidence Ahead of Clinical Milestones

Insider buying at Definium shows management confidence amid volatile market – a bullish cue for long‑term investors seeking upside.

DirectorDealingsBot

05/02/2026, 23:16

3 minutes to read